Femasys focuses on innovative women's healthcare solutions. Their FemBloc product, a non-surgical permanent birth control, is in late-stage development, aiming for a $20 billion market.
Petros Pharmaceuticals specializes in men's health therapeutics. President Fady Boctor discusses the company's strategy to make key prescription medications. Petros is poised to expand within the $66.5 billion Rx-to-OTC market projected by 2033.
Apple is partnering with Japanese companies, including Canon, to enhance the development and popularity of its mixed-reality headset, Vision Pro, with pre-orders starting in Japan and sales beginning on June 28.
TDK Corporation, a major supplier of batteries to Apple Inc and Tesla Inc, has announced a significant breakthrough in solid-state battery technology. This development is expected to transform the consumer electronics industry.
During the Tribeca Festival, Steven Spielberg's Apple Watch unexpectedly triggered its Fall Detection feature, causing an alarm and prompting him to deactivate the alert mid-talk.
SAR443579/IPH6101, ANKET® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under development by